GENE ONLINE|News &
Opinion
Blog

Hereditary Angioedema
Trials & Approvals Hereditary Angioedema
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Trials & Approvals Hereditary Angioedema
FDA Accepts and Boosts sBLA for Takeda’s HAE Treatment for Pediatric Patients
2022-10-06
Asia-Pacific Hereditary Angioedema
Takeda Reveals Positive Data on Takhzyro at EAACI
2022-07-01
Trials & Approvals IONIS-PKK-LRx
Ionis’ Once-Monthly Treatment for Rare Hereditary Disease Achieves Trial Endpoints
2021-03-31
Trials & Approvals Rare Disease
Orladeyo’s FDA approval Heralds New Funding for BioCryst
2020-12-13
Trials & Approvals
ASGCT20: Intellia Presents Data on Two of its CRISPR-Based Novel Therapeutic Candidates
2020-05-16
LATEST
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top